EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH COMORBID GASTROESOPHAGEAL REFLUX DISEASE: A POOLED ANALYSIS OF THE PATHWAY AND NAVIGATOR STUDIES

被引:0
|
作者
Moore, Wendy C.
Lugogo, Njira L.
Chupp, Geoffrey L.
Martin, Nicole
Ambrose, Christopher
Cook, William
Ackert, Jean-Pierre Llanos
机构
关键词
D O I
10.1016/j.chest.2023.07.073
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:4A / 7A
页数:4
相关论文
共 50 条
  • [21] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY
    Castro, Mario
    Cook, William
    Ambrose, Christopher
    Lindsley, Andrew W.
    Hunter, Gillian
    Martin, Neil
    Ponnarambil, Sandhia
    CHEST, 2022, 162 (04) : 35A - 36A
  • [22] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study
    Carr, Tara F.
    Moore, Wendy C.
    Kraft, Monica
    Brusselle, Guy
    Castro, Mario
    Chupp, Geoffrey L.
    Wechsler, Michael E.
    Hunter, Gillian
    Lindsley, Andrew W.
    Llanos, Jean-Pierre
    Burke, Luke K.
    Chandarana, Shradha
    Ambrose, Christopher S.
    ADVANCES IN THERAPY, 2024, 41 (07) : 2978 - 2990
  • [23] Tezepelumab Efficacy by SNOT-22 Domain Scores in Patients With Severe, Uncontrolled Asthma and Comorbid Nasal Polyps in the Phase 3 Navigator Study
    Spahn, J. D.
    Jacobs, J. S.
    Hoyte, F.
    Ambrose, C. S.
    Martin, N.
    Vong, S.
    Caveney, S.
    Cook, B.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and Fungal Sensitization
    Corren, Jonathan
    Mathur, Sameer K.
    Carr, Tara F.
    Wardlaw, Andrew J.
    Caminati, Marco
    Martin, Nicole
    Ponnarambil, Sandhia
    Lindsley, Andrew W.
    Spahn, Joseph D.
    Martin, Neil
    Geffen, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB97 - AB97
  • [25] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
    Carr, Tara
    Bernstein, Jonathan
    Cook, Bill
    Hunter, Gillian
    Ambrose, Chris
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
  • [26] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy
    Corren, Jonathan
    Ambrose, Christopher S.
    Salapa, Kinga
    Roseti, Stephanie L.
    Griffiths, Janet M.
    Parnes, Jane R.
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4334 - +
  • [27] EFFICACY OF TEZEPELUMAB IN HISPANIC OR LATINO PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
    Hill, J.
    Carr, T.
    Ambrose, C.
    Martin, N.
    Ponnarambil, S.
    Lindsley, A.
    Martin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S35 - S35
  • [28] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY PRIOR OMALIZUMAB USE: A POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY
    Menzies-Gow, A.
    Colice, G.
    Ambrose, C. S.
    Martin, N.
    Llanos, J. P.
    Hellqvist, A.
    Cook, B.
    Caminati, M.
    THORAX, 2023, 78 (SUPPL_4) : A273 - A274
  • [29] Effect of Tezepelumab on Exercise Tolerance in Patients With Severe, Uncontrolled Asthma From the NAVIGATOR Study
    Lugogo, N. L.
    Kraft, M.
    Corren, J.
    Martin, N.
    Shenoy, K. V.
    Shenoy, S. F.
    Chandarana, S.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [30] Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)
    Pavord, Ian D.
    Hoyte, Flavia C. L.
    Lindsley, Andrew W.
    Ambrose, Christopher S.
    Spahn, Joseph D.
    Roseti, Stephanie L.
    Cook, Bill
    Grif, Janet M.
    Hellqvist, Asa
    Martin, Nicole
    Llanos, Jean-Pierre
    Martin, Neil
    Colice, Gene
    Corren, Jonathan
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : 587 - 597.e3